BOULDER, Colo. and SAN JOSE, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Rawleigh Ralls, a long-term investor and beneficial owner of 3.7% of Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC), today outlines concerns surrounding lack of financial disclosure for SVVC’s top private portfolio holdings, IntraOp Medical, Hera Systems and WrightSpeed. Firsthand Technology Value Fund is led by Kevin Landis, Chairman of the Board, CEO and President, and Chairman and co-founder of Firsthand Capital Management, Inc., advisor to the Firsthand Funds.

Mr. Ralls’ concern is focused on Mr. Landis’ repeated, multi-year pattern of investing significant new capital in failing portfolio companies. Furthermore, it is apparent that SVVC has been the ONLY investor to fund these companies in recent years, based on SEC filings and Crunchbase.com. The pattern shows that Mr. Landis writes off his previous investments, in a “cram-down” round and invests new money to keep the total valuation of his stake in the companies at high levels. Not only has this proven to be a terrible strategy, delivering a negative 78% share price return over the nearly 10 years with Mr. Landis at the helm; but SVVC also appears to be the only investor at the table willing to fund these enterprises in their failed state.

It would appear that Mr. Landis is well aware of his poor performance managing the fund as the Firsthand Funds website treats SVVC as an ugly stepchild - providing no reference to its stock symbol, performance, NAV or even a datasheet - only a link to an external website.

QMAT Case Study
To illustrate this failed asset management approach, below is an investment chronology for former portfolio company QMAT, based 10-K filings from 2012-2019:

Sadly, the QMAT investments were not a one-time mistake, but rather an unmistakable pattern that can be seen in other portfolio companies also written off to ZERO, such as Aliphcom, Telepathy and VuFine. Worse, the same investment fact pattern exists for current portfolio companies Hera Systems, WrightSpeed and IntraOp Medical, where Mr. Landis has continued spending SVVC fund holder capital, with no other co-investors, for years, presumably to keep these from being written off and enabling him to collect 2% annual management fees.

Given the extremely poor investment pattern and performance, investors should demand more financial disclosure from the Board, Mr. Landis and Firsthand Capital Management, prior to voting at the May 25th annual meeting. Key questions to evaluate the fund’s performance and holdings include:

  1. Are these companies properly capitalized?
  2. What are the last three years’ financials - Balance Sheet and Profit/Loss statements?
  3. Is SVVC the ONLY active investor in these companies?
  4. If so, why are there NO other investors interested in these companies?
  5. What is SVVC’s fully diluted ownership of these portfolio companies?
  6. How much cash do these companies currently have on hand?
  7. What is the current cash runway for these companies?
  8. How much additional capital will they need to reach cash flow breakeven, and where will that investment come from?
  9. Does the independent company valuing these portfolio positions take these facts into consideration?
  10. Why won’t Mr. Landis make himself available to shareholders, provide quarterly portfolio company updates and more detailed portfolio company financials?

Mr. Ralls urges investors to demand that the SVVC Board of Directors and Firsthand Capital Management host an investor Zoom meeting to discuss these issues BEFORE the 2021 Annual Meeting of Stockholders on May 25, 2021 - or to adjourn the annual meeting to provide sufficient time for such a meeting to occur.

Investors can request this meeting by contacting Mr. Landis or Phil Mosakowski, at:

Kevin Landis
Phil Mosakowski
408-624-9533
408-624-9526

Rawleigh Ralls has over 30 years’ experience in the investment community, including an eight-year career at Goldman Sachs and as co-founder of two investment funds, Precept Capital Management and Lacuna Capital LLC. He is currently a director on six company boards, including one public (Tucows, Inc. Nasdaq: TCX) and five private companies in the software and technology space. Mr. Ralls has been on numerous other company boards, raised considerable investment capital and advised many public and private company management teams. Mr. Ralls graduated from the University of Arkansas in 1984 and received an MBA from Southern Methodist University.

IMPORTANT INFORMATION CONCERNING THIS COMMUNICATION
This press release is being issued pursuant to Rule 14a-2(b)(1) promulgated under the Securities Exchange Act of 1934. This is not a solicitation of authority to vote your proxy. I am not asking for your proxy card and will not accept proxy cards if sent. The cost of this communication is being borne entirely by Rawleigh Ralls.

Contact:
Rawleigh Ralls
rallsrawleigh@gmail.com